Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2020 Nov 20

PMID 33215031

Citations 7

Authors

Nannan Zhang

Feilong Ning

Rui Guo

Junpeng Pei

Yun Qiao

Jin Fan

Bo Jiang

Yanlong Liu

Zhaocheng Chi

Zubing Mei

Masanobu Abe

Ji Zhu

Rui Zhang

Chundong Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Increasing evidence indicates that inflammation and nutritional status are associated with survival outcomes in patients with colorectal cancer (CRC). This study aimed to investigate the prognostic values of preoperative inflammatory and nutritional factors and develop a prognostic model individually predicting overall survival (OS) and disease-free survival (DFS) in patients with CRC.

Methods: We retrospectively collected data on patients with CRC who underwent radical surgery. Independent prognostic inflammatory and nutritional markers were identified and novel prognostic models were developed incorporating the identified factors. The discriminative ability and model-fitting performance were evaluated by receiver operating characteristic curves and Akaike information criteria. Clinical usefulness was assessed by decision curve analysis.

Results: A total of 400 eligible patients were identified. Multivariate analysis identified pN stage, tumor differentiation grade, neutrophil count, and body mass index as independent prognostic factors for OS, and pN stage, tumor differentiation grade, neutrophil count, neutrophil-lymphocyte ratio, and serum albumin as prognostic factors for DFS. The combined inflammatory and nutritional prognostic model showed better discriminative ability, model-fitting performance, and net benefits than the inflammatory and nutritional models alone, and the American Joint Committee on Cancer (AJCC) 8th TNM classification for predicting OS and DFS.

Conclusion: Preoperative nutritional and inflammatory factors have significant prognostic value in patients with CRC. A novel prognostic model incorporating preoperative inflammatory and nutritional markers provides better prognostic performance than the AJCC 8th TNM classification. A novel nomogram incorporating preoperative inflammatory and nutritional markers can individually predict OS and DFS in patients with CRC.

Citing Articles

Optimal cutpoint of preoperative neutrophil-lymphocyte ratio and associated postoperative prognosis in colorectal cancer patients.

Chiu T, Liu T, Chang C, Hu W Int J Colorectal Dis. 2025; 40(1):55.

PMID: 40009243 PMC: 11865130. DOI: 10.1007/s00384-025-04839-4.

[Predictive Value of Prognostic Nutritional Index in Prognosis and  Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer  and Malignant Pleural Effusion].

Tan S, Li W, Tian P Zhongguo Fei Ai Za Zhi. 2025; 27(12):931-939.

PMID: 39962848 PMC: 11843482. DOI: 10.3779/j.issn.1009-3419.2024.106.33.

Development and validation of a web-based predictive model for preoperative diagnosis of localized colorectal cancer and colorectal adenoma.

Lu Y, Guo H, Jiang J Front Oncol. 2023; 13:1199868.

PMID: 37664051 PMC: 10470828. DOI: 10.3389/fonc.2023.1199868.

Increased Kremen2 predicts worse prognosis in colon cancer.

Long J, Cong F, Wei Y, Liu J, Tang W Pathol Oncol Res. 2023; 29:1611082.

PMID: 37123533 PMC: 10130194. DOI: 10.3389/pore.2023.1611082.

Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients.

Wu T, Xu H, Zou Y, Cui J, Xu K, Zhou M Nutrients. 2022; 14(23).

PMID: 36501196 PMC: 9739446. DOI: 10.3390/nu14235166.

References

Ronnow C, Arthursson V, Toth E, Krarup P, Syk I, Thorlacius H . Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg. 2020; 275(1):e148-e154. DOI: 10.1097/SLA.0000000000003854. View

Yeung S, Hilkewich L, Gillis C, Heine J, Fenton T . Protein intakes are associated with reduced length of stay: a comparison between Enhanced Recovery After Surgery (ERAS) and conventional care after elective colorectal surgery. Am J Clin Nutr. 2017; 106(1):44-51. DOI: 10.3945/ajcn.116.148619. View

Nagtegaal I, Knijn N, Hugen N, Marshall H, Sugihara K, Tot T . Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. J Clin Oncol. 2016; 35(10):1119-1127. DOI: 10.1200/JCO.2016.68.9091. View

Sjoquist K, Renfro L, Simes R, Tebbutt N, Clarke S, Seymour M . Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. J Natl Cancer Inst. 2017; 110(6):638-648. PMC: 6005015. DOI: 10.1093/jnci/djx253. View

Houghton A, Rzymkiewicz D, Ji H, Gregory A, Egea E, Metz H . Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med. 2010; 16(2):219-23. PMC: 2821801. DOI: 10.1038/nm.2084. View

Holch J, Ricard I, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A . Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). Eur J Cancer. 2018; 106:115-125. DOI: 10.1016/j.ejca.2018.10.001. View

Chojkier M . Inhibition of albumin synthesis in chronic diseases: molecular mechanisms. J Clin Gastroenterol. 2005; 39(4 Suppl 2):S143-6. DOI: 10.1097/01.mcg.0000155514.17715.39. View

Dienstmann R, Villacampa G, Sveen A, Mason M, Niedzwiecki D, Nesbakken A . Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Ann Oncol. 2019; 30(10):1622-1629. PMC: 6857614. DOI: 10.1093/annonc/mdz287. View

Reisinger K, van Vugt J, Tegels J, Snijders C, Hulsewe K, Hoofwijk A . Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2014; 261(2):345-52. DOI: 10.1097/SLA.0000000000000628. View

10.

Wang J, Song Y, Liu X, Jin J, Wang W, Yu Z . Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk. Cancer Med. 2019; 8(3):902-909. PMC: 6434203. DOI: 10.1002/cam4.1919. View

11.

Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy R, Faiz O . A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg. 2013; 260(2):287-92. DOI: 10.1097/SLA.0000000000000216. View

12.

Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kondo T . Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2016; 267(3):527-531. DOI: 10.1097/SLA.0000000000002115. View

13.

Diefenhardt M, Hofheinz R, Martin D, Beissbarth T, Arnold D, Hartmann A . Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial. Int J Cancer. 2019; 145(8):2282-2291. DOI: 10.1002/ijc.32274. View

14.

Halazun K, Aldoori A, Malik H, Al-Mukhtar A, Prasad K, Toogood G . Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2007; 34(1):55-60. DOI: 10.1016/j.ejso.2007.02.014. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Okuno M, Goumard C, Kopetz S, Vega E, Joechle K, Mizuno T . Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. 2018; 165(2):329-336. DOI: 10.1016/j.surg.2018.07.031. View

17.

Ko W, Helzlsouer K, Comstock G . Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J Natl Cancer Inst. 1994; 86(24):1874-5. DOI: 10.1093/jnci/86.24.1874. View

18.

Chan J, Chan D, Diakos C, Engel A, Pavlakis N, Gill A . The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2016; 265(3):539-546. PMC: 5300029. DOI: 10.1097/SLA.0000000000001743. View

19.

Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch K . The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg. 2010; 251(6):1070-8. DOI: 10.1097/SLA.0b013e3181d7789d. View

20.

Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T . Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer. 2005; 8(2):124-31. DOI: 10.1007/s10120-005-0315-x. View